GH Research PLC
GHRS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001855129
No open-market purchases or sales by GH Research PLC insiders were filed in the last 90 days; 63 institutions reported holding it in 13F filings for Q2 2026, worth $1.38B in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in GH Research PLC as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 34
- +34 vs. Q1 2021
- Shares held
- 27.6M
- +27.6M vs. Q1 2021
- Total value
- $593.7M
- +$593.7M vs. Q1 2021
- New holders
- 34
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GHRS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 63 | $1.38B |
| Q1 2026 | 54 | $668.5M |
| Q4 2025 | 53 | $591.4M |
| Q3 2025 | 47 | $618.1M |
| Q2 2025 | 38 | $530.9M |
| Q1 2025 | 36 | $470.1M |
| Q4 2024 | 31 | $214.9M |
| Q3 2024 | 28 | $204.2M |
| Q2 2024 | 28 | $354.8M |
| Q1 2024 | 32 | $315.5M |
| Q4 2023 | 35 | $171.7M |
| Q3 2023 | 29 | $291.5M |
| Q2 2023 | 34 | $351.6M |
| Q1 2023 | 29 | $237.2M |
| Q4 2022 | 32 | $299.5M |
| Q3 2022 | 34 | $367.2M |
| Q2 2022 | 35 | $325.0M |
| Q1 2022 | 33 | $587.1M |
| Q4 2021 | 30 | $701.0M |
| Q3 2021 | 30 | $625.2M |
| Q2 2021 | 34 | $593.7M |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding GH Research PLC; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BVF Inc | 9,275,156 | $201.5M | 7.55% | +9,275,156 | New |
| Ra Capital Management, L.P. | 2,978,955 | $64.7M | 1.04% | +2,978,955 | New |
| RTW Investments, LP | 2,168,957 | $42.7M | 0.64% | +2,168,957 | New |
| OrbiMed Advisors LLC | 1,428,666 | $31.0M | 0.32% | +1,428,666 | New |
| FMR LLC | 1,361,694 | $29.6M | 0.00% | +1,361,694 | New |
| Verition Fund Management LLC | 1,338,124 | $29.1M | 0.43% | +1,338,124 | New |
| VR Adviser, LLC | 1,275,831 | $27.7M | 3.36% | +1,275,831 | New |
| Citadel Advisors LLC | 1,283,790 | $27.1M | 0.03% | +1,283,790 | New |
| Boxer Capital, LLC | 1,013,399 | $22.0M | 0.78% | +1,013,399 | New |
| Logos Global Management LP | 724,333 | $15.7M | 1.35% | +724,333 | New |
| Cormorant Asset Management, LP | 608,123 | $12.6M | 0.49% | +608,123 | New |
| Avidity Partners Management LP | 560,000 | $12.2M | 0.33% | +560,000 | New |
| Deerfield Management Company, L.P. (Series C) | 555,416 | $12.1M | 0.21% | +555,416 | New |
| Adage Capital Partners GP, L.L.C. | 465,000 | $10.1M | 0.02% | +465,000 | New |
| TimesSquare Capital Management, LLC | 422,289 | $9.18M | 0.08% | +422,289 | New |
| Pura Vida Investments, LLC | 400,000 | $8.69M | 0.62% | +400,000 | New |
| Laurion Capital Management LP | 360,000 | $7.82M | 0.12% | +360,000 | New |
| HealthCor Management, L.P. | 250,000 | $5.43M | 0.22% | +250,000 | New |
| Morgan Stanley | 201,728 | $4.38M | 0.00% | +201,728 | New |
| Monashee Investment Management LLC | 165,000 | $3.58M | 0.43% | +165,000 | New |
| Acuta Capital Partners, LLC | 150,000 | $3.26M | 1.40% | +150,000 | New |
| Woodline Partners LP | 138,897 | $3.02M | 0.06% | +138,897 | New |
| Alyeska Investment Group, L.P. | 100,000 | $2.17M | 0.03% | +100,000 | New |
| Maven Securities LTD | 100,000 | $2.17M | 0.23% | +100,000 | New |
| Walleye Capital LLC | 85,100 | $1.85M | 0.07% | +85,100 | New |
| Pinz Capital Management, LP | 68,500 | $1.49M | 0.45% | +68,500 | New |
| Millennium Management LLC | 45,866 | $997.0K | 0.00% | +45,866 | New |
| Polar Asset Management Partners Inc. | 19,624 | $426.0K | 0.01% | +19,624 | New |
| Squarepoint Ops LLC | 18,000 | $391.0K | 0.00% | +18,000 | New |
| Qube Research & Technologies Ltd | 17,525 | $381.0K | 0.00% | +17,525 | New |
| Capstone Investment Advisors, LLC | 10,000 | $217.0K | 0.01% | +10,000 | New |
| BlackRock Inc. | 1,000 | $21.0K | 0.00% | +1,000 | New |
| Tower Research Capital LLC (TRC) | 837 | $18.0K | 0.00% | +837 | New |
| UBS Group AG | 335 | $7.00K | 0.00% | +335 | New |